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A case of severe haemolytic disease of
the newborn due to anti-Dia antibody
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Red cell allo-antibodies directed against the Diego (Di) blood group antigen
have rarely been reported to cause a haemolytic reaction against transfu-
sion or haemolytic disease of the newborn. The frequency of the Di(a+)
phenotype among the Hong Kong Chinese population is estimated to be
4.4%. We report on a case of severe haemolytic disease of the newborn
due to anti-Dia antibody—the first local case to the best of our knowledge.
Rare but clinically significant antibodies targeting red blood cells have to be
considered in the investigation of haemolytic disease of the newborn when
common underlying factors have been eliminated.
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Introduction
The role of anti-Dia antibody in causing haemolytic disease of newborn was first
recognised in 1955.1 Genetic studies reveal that there is great variation in the
distribution of the Dia antigen in different populations. It is relatively common
among Asian and South Americans, as compared with Caucasians.2 Here we
report the first local case of severe haemolytic disease of the newborn due to
anti-Dia antibody.
Case report
A baby girl was born at 38 weeks of gestation by vaginal delivery. She was the
second child of a non-consanguineous couple, whose first child was healthy.
The antenatal course was unremarkable. Routine screening for allo-antibodies
against red blood cells at the first antenatal visit gave negative results. The
baby’s birthweight was 3105 g and the placenta weighed 750 g. Meconium-
stained liquor was noted at birth. Physical examination revealed a pale and
jaundiced baby. The liver and spleen were enlarged to 4 cm and 2 cm below the
costal margin, respectively. There was no hydropic change and no evidence of
acute haemorrhage.
Initial investigations at birth showed that the haemoglobin level was 59 g/L,
the white blood cell count (corrected for nucleated red blood cells) was
26.3 x 109 /L, and the platelet count was 76 x 109 /L. The peripheral blood
film showed a leuko-erythoblastic picture and many circulating nucleated
red blood cells (170 per 100 white blood cells), as well as polychromasia and
the presence of spherocytes. Furthermore, there was significant reticulocytosis
(27% of red cell count). The serum haptoglobin level was low, at less than
0.05 g/L (reference range, 0.16-1.97 g/L), whereas the whole-blood methaemal-
bumin level was high, at 27 mg/L (reference level, <1 mg/L). Liver function tests
showed predominant unconjugated hyperbilirubinaemia. The total serum bilirubin
level at 3 hours of life was 186 µmol/L (threshold for exchange transfusion was
approximately 130 µmol/L).
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Serial investigations were conducted to determine the
cause of severe anaemia and haemolysis. Tests for cord-
blood glucose-6-phosphate dehydrogenase level and thyroid
function gave normal results. Investigations to detect
sepsis, including blood cultures and surface swabs, yielded
no organisms. Screening for congenital viral infection, in-
cluding rubella and toxoplasmosis, also gave negative results.
Autoimmune markers and immunoglobulin (Ig) levels were
unremarkable. Parvovirus IgM was absent. Haemoglobin
pattern analysis showed no significant abnormality, and a
Heinz body preparation was negative.
Direct Coombs’ testing on foetal red blood cells was
strongly positive, both for polyspecific anti-human
globulin and anti-IgG. The maternal blood was group B,
Rh D-positive and the baby’s blood was group AB, Rh
D-positive. Maternal red blood cells gave negative results
in the direct Coombs’ test. No antibodies against red blood
cells were identified in tests using commercial screen cells
(DiaCell; DiaMed AG, 1785 Cressier s/Morat, Switzerland),
and two screen cells from the Hong Kong Red Cross Blood
Transfusion Service. The screen cells from both sources
expressed the most frequently occurring and important red
blood cell antigens, including Mia, but they did not express
Dia. However, compatibility testing during preparation for
exchange transfusion showed that, among eight blood units
selected, one was incompatible with maternal serum. An
irregular antibody was thus suspected, and was indeed
identified in the maternal serum from tests with an exten-
sive panel of red blood cells: the specificity of the antibody
was subsequently characterised as anti-Dia. Maternal red
blood cells were then found to be Di(a)-negative, whereas
red blood cells of the baby and her father were Di(a)-positive.
The incompatible blood unit was also typed to be Di(a+b+).
The overall picture was consistent with severe haemolytic
disease of the newborn due to an anti-Dia antibody. Elution
studies using foetal red blood cells were not performed to
confirm the identity of the antibody, because exchange
transfusion was urgently needed and the pretransfusion blood
sample was inadequate for study.
The serum bilirubin level increased to 270 µmol/L at
8 hours of life despite intensive phototherapy. Double-
volume exchange transfusion (ie using twice the estimated
blood volume of the baby) was performed with group
B and group O, Rh-positive whole blood. The bilirubin level
dropped to an acceptable range only after three double-
volume exchange transfusions. A total of 1165 mL fresh
whole blood was used. The baby’s condition remained
stable after exchange transfusion. She was ultimately
discharged on day 8 of life. Clinical follow-up until 2 years
of age showed no residual anaemia or abnormal neuro-
development. The brainstem-evoked potential at 3 months
was within the normal range. Repeated blood counts and
liver function test results were all unremarkable. The most
recent blood counts, at 18 months, were as follows:
haemoglobin, 136 g/L; white blood cell count, 12 x109 /L;
and platelet count, 266 x 109 /L.
Discussion
Blood group antigens comprise a wide range of molecules
that have various biological functions on the erythrocyte
membrane. The Di blood group system consists of nine
antigens,3 including two independent pairs of alleles: Dia/
Dib and Wra/Wrb. They belong to one of the three red blood
cell membrane transporters4 that are encoded by a gene on
chromosome 17q12-q21.5 The three red blood cell mem-
brane transporters are called band 3 (Di system antigen),
aquaporin 1 (Colton antigen), and HUT 11 (Kidd antigen).
The Di system antigen acts as an anion exchanger that
permits bicarbonate (hydrogencarbonate) ions to cross the
membrane in exchange for chloride ions. The transport of
bicarbonate ions in the plasma thus greatly increases the
quantity of carbon dioxide that the blood can convey to
the lungs.4 This antigen also helps maintain the structural
integrity of the erythrocyte membrane by stabilising mem-
brane lipids.6 It may also be involved in the removal of
senescent red cells from the circulation.6
The anti-Dia antibodies are polyclonal IgGs of the
subclass IgG1 and IgG3. Unlike other antibodies of this Ig
subclass, anti-Dia antibodies are unable to trigger comple-
ment activation. They can, however, induce macrophage
phagocytosis of sensitised red blood cells.7 Anti-Dia
antibody was first recognised when it caused haemolytic
disease in a baby born to a Venezuelan woman in 1955.1
Several similar cases were subsequently described in Asia
(Table).1,7-9 Some, but not all, cases were severe enough to
require exchange transfusion.9 The reason for the variation
in clinical severity of anti-Dia antibody–induced haemolytic
disease of the newborn remains unknown but, as in cases of
the disease caused by other red blood cell antibodies, the
degree of haemolysis may depend on the maternal antibody
concentration, the IgG subclass of the antibody, and the bio-
logical activity of the antibody as determined from cellular
bioassays. Another potential modifying factor is the
presence of maternal antibodies that can block the Fc-
receptor and which can interfere with the binding of IgG-
coated red blood cells to foetal macrophages, thereby
reducing or preventing the haemolytic process. This situ-
ation has been shown in haemolytic disease of the newborn
related to anti-D antibody.10 There is no known case of hy-
Table. Summary of reports of anti-Dia antibody causing
haemolytic disease of newborn
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Haemolytic disease of newborn due to anti-Dia
drops foetalis related to the Di blood group–incompatible
couples reported so far.
The main importance of the Di blood group is in an-
thropology, rather than haematology, because of its
distinct racial distribution. The Dia antigen is very rare
among Caucasians, but is relatively common (5%-15%)
among South American Indians and Asian populations.2
In a study of the distribution of various blood group
antigens in Taiwan, the frequency of the Dia antigen among
different Chinese ethnic groups was as follows: Minnan,
3.2%; Hakka, 7.0%; descendants of mainland Chinese from
the south of Yangtse River, 3.2%; and descendants of
mainland Chinese from the north of Yangtse, 10.3%.11 From
Chinese history, we know that the Hakka migrated to South
China hundreds of years ago from northern China. The
Hakka bloodline has stayed relatively pure, without much
mixing with the indigenous people of the southeastern
coastal area of China. Some researchers believe that
Japanese descendants came from northern China. It is thus
not surprising that the frequency of the Dia antigen among
Hakka, northern Chinese, and Japanese populations is quite
similar. The reported Dia antigen frequency in Hong Kong
and Japan are 4.4% and 9.3%, respectively.12
Conclusion
Given that the reported Dia+ antigen frequency in Hong Kong
is 4.4%, and that antibodies directed against the Di blood
group system are clinically significant, it is worthwhile to
consider anti-Dia antibody as a cause of haemolytic dis-
ease of the newborn when more common red blood cell
antibodies are excluded. When red blood cells aimed at
testing against a Dia+ panel are not immediately available, a
compatibility test between paternal red blood cells against
maternal serum, provided that they are ABO-compatible,
may reveal the presence of uncommon antibodies in the
maternal circulation.
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